Jasper Therapeutics, Inc. SEC filings JSPR
Jasper Therapeutics, Inc. has 483 filings in SEC EDGAR's recent list, going back to Sep 13, 2019. Its latest annual report, Form ARS, was filed on Jun 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (change to shareholder rights, bylaw or fiscal year change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Nov 4, 2026 | Nov 2, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 28, 2026 | — |
| SC TO-I/A | Amendment no. 1 to form sc to-i | Oct 23, 2026 | — |
| DEF 14A | Proxy statement | Oct 19, 2026 | Nov 13, 2026 |
| 8-K |
Current report
Other events
|
Oct 15, 2026 | Oct 15, 2026 |
| S-3 | Shelf registration | Oct 14, 2026 | — |
| PRE 14A | Preliminary proxy statement | Oct 9, 2026 | Oct 9, 2026 |
| 8-K |
Current report
Other events
|
Oct 7, 2026 | Oct 7, 2026 |
| SC TO-I | Form sc to-i | Oct 7, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Oct 5, 2026 | Sep 30, 2026 |
| 8-K/A | Amended current report | Oct 5, 2026 | Jul 16, 2026 |
| 8-K/A | Amended current report | Oct 1, 2026 | Jul 16, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 28, 2026 | Sep 23, 2026 |
| 25-NSE | Delisting notice | Sep 24, 2026 | — |
| DEF 14A | Proxy statement | Sep 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Material agreement
|
Aug 26, 2026 | Aug 21, 2026 |
| PRE 14A | Preliminary proxy statement | Aug 24, 2026 | Aug 24, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 17, 2026 | — |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| D | Filing | Aug 5, 2026 | — |
| 4 | Insider transaction | Aug 4, 2026 | Jul 31, 2026 |
| 4 | Insider transaction | Aug 4, 2026 | Jul 31, 2026 |
| 4 | Insider transaction | Aug 4, 2026 | Jul 31, 2026 |
| 4 | Insider transaction | Aug 4, 2026 | Jul 31, 2026 |
| 4 | Insider transaction | Aug 4, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Aug 3, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Other events
|
Jul 31, 2026 | Jul 31, 2026 |
| 3 | Initial insider ownership | Jul 23, 2026 | Jul 16, 2026 |
| 4 | Insider transaction | Jul 22, 2026 | Jul 20, 2026 |
| 3 | Initial insider ownership | Jul 22, 2026 | Jul 16, 2026 |
| 3 | Initial insider ownership | Jul 22, 2026 | Jul 16, 2026 |
| 4 | Insider transaction | Jul 20, 2026 | Jul 16, 2026 |
| 3 | Initial insider ownership | Jul 20, 2026 | Jul 16, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 20, 2026 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Jul 17, 2026 | Jul 16, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 16, 2026 | Jul 16, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 10, 2026 | — |
| ARS | Annual report to shareholders | Jun 15, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Jun 15, 2026 | — |
| DEF 14A | Proxy statement | Jun 15, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Listing notice
|
Jun 9, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 1, 2026 | Jun 1, 2026 |
| 8-K |
Current report
Officer or director change
|
May 21, 2026 | May 15, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 8, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 8, 2026 | — |
| 10-K/A | Amended annual report | Apr 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2026 | Mar 30, 2026 |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 25, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 18, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 12, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 11, 2026 | — |
| 4 | Insider transaction | Feb 10, 2026 | Feb 6, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 26, 2026 | — |
| 8-K |
Current report
Other events
|
Jan 8, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Jan 7, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 2, 2025 | — |
| 8-K |
Current report
Other events
|
Dec 2, 2025 | Dec 2, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 12, 2025 | — |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 7, 2025 | — |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 23, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Sep 19, 2025 | Sep 18, 2025 |
| 424B5 | Prospectus supplement | Sep 19, 2025 | — |
| 424B5 | Prospectus supplement | Sep 18, 2025 | — |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 6, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 17, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 11, 2025 | — |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Other events
|
Jul 9, 2025 | Jul 8, 2025 |
| 8-K |
Current report
Other events
|
Jul 7, 2025 | Jul 7, 2025 |
| 4 | Insider transaction | Jul 3, 2025 | Jul 3, 2025 |
| 4 | Insider transaction | Jul 3, 2025 | Jul 3, 2025 |
| 4 | Insider transaction | Jul 3, 2025 | Jul 3, 2025 |
| 4 | Insider transaction | Jul 3, 2025 | Jul 3, 2025 |
| 4 | Insider transaction | Jul 3, 2025 | Jul 3, 2025 |
| 4 | Insider transaction | Jul 3, 2025 | Jul 3, 2025 |
| 4 | Insider transaction | Jul 3, 2025 | Jul 3, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jul 3, 2025 | Jul 3, 2025 |
| 8-K |
Current report
Other events
|
Jun 16, 2025 | Jun 14, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 4, 2025 |
| ARS | Annual report to shareholders | May 19, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | May 19, 2025 | — |
| DEF 14A | Proxy statement | May 19, 2025 | Jul 3, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| EFFECT | Filing | Mar 26, 2025 | — |
| 424B5 | Prospectus supplement | Mar 26, 2025 | — |
| CORRESP | Letter to the SEC | Mar 24, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 21, 2025 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Mar 19, 2025 | Mar 14, 2025 |
| S-3 | Shelf registration | Mar 19, 2025 | — |
| 10-K | Annual report | Feb 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2025 | Feb 27, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 11, 2025 | — |
| 8-K |
Current report
Other events
|
Jan 8, 2025 | Jan 8, 2025 |
| 4 | Insider transaction | Dec 12, 2024 | Dec 12, 2024 |
| 144 | Notice of proposed sale | Dec 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 4, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 22, 2024 | — |
| 8-K |
Current report
Other events
|
Oct 15, 2024 | Oct 14, 2024 |
| 4 | Insider transaction | Sep 12, 2024 | Sep 12, 2024 |
| 144 | Notice of proposed sale | Sep 12, 2024 | — |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Jun 20, 2024 | Jun 18, 2024 |
| 3 | Initial insider ownership | Jun 20, 2024 | Jun 18, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Jun 20, 2024 | Jun 17, 2024 |
| 4 | Insider transaction | Jun 12, 2024 | Jun 12, 2024 |
| 144 | Notice of proposed sale | Jun 12, 2024 | — |
| 4 | Insider transaction | Jun 12, 2024 | Jun 10, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 12, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| S-8 POS | Post effective amendment no. 1 to form s-8 | Jun 7, 2024 | — |
| S-8 POS | Post effective amendment no. 1 to form s-8 | Jun 7, 2024 | — |
| S-8 POS | Post effective amendment no. 1 to form s-8 | Jun 7, 2024 | — |
| S-8 | Employee stock plan registration | Jun 7, 2024 | — |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| DEFA14A | Additional proxy material | May 3, 2024 | — |
| ARS | Annual report to shareholders | Apr 22, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 22, 2024 | — |
| DEF 14A | Proxy statement | Apr 22, 2024 | Jun 6, 2024 |
| SC 13G | Ownership over 5% (passive) | Mar 27, 2024 | — |
| 4 | Insider transaction | Mar 12, 2024 | Mar 12, 2024 |
| 144 | Notice of proposed sale | Mar 12, 2024 | — |
| 144 | Notice of proposed sale | Mar 6, 2024 | — |
| S-8 | Employee stock plan registration | Mar 5, 2024 | — |
| 10-K | Annual report | Mar 5, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 4, 2024 | Mar 4, 2024 |
| 4 | Insider transaction | Feb 20, 2024 | Feb 15, 2024 |
| 4 | Insider transaction | Feb 20, 2024 | Feb 15, 2024 |
| 4 | Insider transaction | Feb 20, 2024 | Feb 15, 2024 |
| 4 | Insider transaction | Feb 20, 2024 | Feb 15, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| 4 | Insider transaction | Feb 12, 2024 | Feb 8, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Feb 12, 2024 | — |
| 4 | Insider transaction | Feb 9, 2024 | Feb 8, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Feb 9, 2024 | — |
| 424B5 | Prospectus supplement | Feb 7, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Feb 6, 2024 | Feb 6, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 5, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 2, 2024 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jan 4, 2024 | Jan 3, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 2, 2024 | Jan 2, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Dec 20, 2023 | Dec 15, 2023 |
| 4 | Insider transaction | Nov 30, 2023 | Nov 28, 2023 |
| 4 | Insider transaction | Nov 22, 2023 | Nov 21, 2023 |
| 4 | Insider transaction | Nov 20, 2023 | Nov 16, 2023 |
| DEF 14A | Proxy statement | Nov 20, 2023 | Dec 15, 2023 |
| PRE 14A | Preliminary proxy statement | Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 4 | Insider transaction | Nov 2, 2023 | Nov 1, 2023 |
| 3 | Initial insider ownership | Nov 2, 2023 | Nov 1, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Nov 1, 2023 | Oct 30, 2023 |
| 8-K |
Current report
Listing notice
|
Oct 20, 2023 | Oct 18, 2023 |
| 4 | Insider transaction | Oct 13, 2023 | Oct 12, 2023 |
| 4 | Insider transaction | Oct 13, 2023 | Oct 12, 2023 |
| 4 | Insider transaction | Oct 13, 2023 | Oct 13, 2023 |
| 144 | Notice of proposed sale | Oct 13, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Oct 10, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 10, 2023 | Oct 10, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 10, 2023 | Oct 9, 2023 |
| 4 | Insider transaction | Sep 26, 2023 | Sep 22, 2023 |
| 3 | Initial insider ownership | Sep 26, 2023 | Sep 22, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- JSPR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Redwood City, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1788028
- Former names
- Amplitude Healthcare Acquisition Corp (until Sep 29, 2021)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.